Sutureless Purely Off-clamp Robotic Partial Nephrectomy: Evidence from a Randomized Controlled Noninferiority Trial

医学 置信区间 肾切除术 随机化 随机对照试验 临床终点 外科 肾功能 肾癌 失血 临床试验 泌尿科 肾脏疾病 围手术期 泌尿系统 意向治疗分析 肾细胞癌 肾病科
作者
Aldo Brassetti,Gabriele Tuderti,Umberto Anceschi,Alfredo Maria Bove,Eugenio Bologna,Lorenzo Capecchi,Giuseppe Chiacchio,Simone D’Annunzio,Mariaconsiglia C. Ferriero,Rocco Simone Flammia,Salvatore Guaglianone,Sabrina Iuculano,Claudia Denaro,Arianna Di Luzio,Costantino Leonardo,Leslie Claire Licari,Riccardo Mastroianni,Leonardo Misuraca,Flavia Proietti,Isabella Sperduti
出处
期刊:European Urology [Elsevier BV]
卷期号:90 (3): 291-300 被引量:11
标识
DOI:10.1016/j.eururo.2026.04.019
摘要

BACKGROUND AND OBJECTIVE: The sutureless (SL) purely off-clamp robotic partial nephrectomy (ocRPN) technique has been proposed to minimize postoperative functional damage. We assessed whether this approach is noninferior to renorrhaphy (RR) in terms of surgical quality. METHODS: Patients with cT1-2N0M0 renal tumors were randomly assigned to SL or RR-ocRPN within a single-center, single-surgeon randomized controlled trial (NCT06846112). A covariate-adaptive 1:1 randomization algorithm ensured balance between treatment arms for age, sex, baseline renal function, and tumor surgical complexity. The primary endpoint was Trifecta achievement at discharge. A prespecified noninferiority test (margin -10%) compared Trifecta rates using one-sided testing and confidence intervals. Secondary outcomes were descriptively analyzed and compared between study arms. Recurrence-free survival (RFS) was estimated using the Kaplan-Meier method. KEY FINDINGS AND LIMITATIONS: Among 248 patients, baseline characteristics were balanced. Trifecta was achieved in 93% and 95% of cases (absolute difference -2.4%; 90% confidence interval [CI] -7.4%-2.6%), meeting the criterion for noninferiority (one-sided p = 0.006). Blood transfusions (2.4% vs 0%) and acute kidney injury (1.6% in both groups) were rare. Nine urinary fistulae occurred overall, all managed with temporary stenting; rates were higher in the SL group but not statistically significant (p = 0.08). Renal function remained stable up to 12 mo, and 1-yr RFS was 99% in all cohorts. Limitations include single-center design, surgeon expertise, and short oncologic follow-up. CONCLUSIONS AND CLINICAL IMPLICATIONS: SL-ocRPN is safe and effective and represents a feasible alternative to RR-ocRPN in selected cT1-2N0M0 renal tumors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
我是谁的应助被mmmm采纳,获得20
1秒前
RZ驳回了秋风的应助
2秒前
nnnnn完成签到 ,获得积分10
3秒前
共享精神的应助被吃面不加醋采纳,获得10
3秒前
白简完成签到,获得积分20
4秒前
无花果的应助被Atlantis30采纳,获得10
4秒前
田様的应助被ari采纳,获得10
5秒前
朝夕发布了新的文献求助10
5秒前
Owen的应助被风-FBDD采纳,获得10
5秒前
Lytoo完成签到 ,获得积分10
5秒前
应万言完成签到,获得积分0
6秒前
7秒前
8秒前
彭于晏的应助被jiajia采纳,获得10
8秒前
在水一方的应助被开心德地采纳,获得10
8秒前
9秒前
hi完成签到,获得积分10
10秒前
kk完成签到,获得积分10
10秒前
欣喜安莲完成签到,获得积分10
10秒前
11秒前
敏感问晴完成签到,获得积分10
11秒前
XZJ发布了新的文献求助10
12秒前
miao完成签到 ,获得积分10
14秒前
15秒前
且寄流心完成签到,获得积分10
15秒前
了尘完成签到,获得积分10
15秒前
求助文献发布了新的文献求助10
15秒前
16秒前
子翱完成签到 ,获得积分10
16秒前
田様的应助被清平乐采纳,获得10
16秒前
叶子完成签到,获得积分10
16秒前
白简发布了新的文献求助10
16秒前
17秒前
852的应助被壮观的晓露采纳,获得10
17秒前
秋风的应助被wg采纳,获得10
17秒前
敏感问晴发布了新的文献求助10
17秒前
17秒前
李梦晓发布了新的文献求助10
17秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188785
求助须知:如何正确求助?哪些是违规求助? 9576421
关于积分的说明 21847553
捐赠科研通 7786814
什么是DOI,文献DOI怎么找? 3435417
关于科研通互助平台的介绍 2559647
邀请新用户注册赠送积分活动 2482366